Investment
Features
FeesSafety
Academy
More
Pluang+

Journey Energy reports Q1 2026 loss of $5.8M amid commodity price volatility, plans increased capital spending.

Company Fundamentals
07 May 2026
Newsfile Corp
View Source
Neutral
pluang ai news

Journey Energy Inc. reported a net loss of $5.8 million in Q1 2026, impacted by a $9 million mark-to-market loss on commodity hedges due to volatile oil prices from the US-Iran war. Despite a 5% drop in sales volumes to 10,456 boe/d, the company realized $13.7 million in adjusted funds flow and plans to increase 2026 capital spending to $80-$90 million, focusing on Duvernay light oil development and power projects. Journey forecasts production growth with new wells coming online mid-year and aims to market non-core assets to fund further development. The company remains optimistic about commodity price tailwinds improving future cash flow and growth prospects.

More News

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...

Market News
Bullish
3 hours ago
B&M's Q1 update splits analysts as Deutsche Bank upgrades but Panmure Liberum downgrades on growth doubts

B&M's Q1 update splits analysts as Deutsche Bank upgrades but Panmure Liberum downgrades on growth doubts

B&M European Value Retail's first-quarter update has divided analysts, with Deutsche Bank upgrading the stock to 'hold' citing stabilizing profit margins and a sensible turnaround strategy by new CEO Tjeerd Jegen. Deutsche Bank raised its profit fore...

Analyst Insights
Neutral
4 hours ago
Telo Genomics reports positive interim results for blood test predicting relapse risk in multiple myeloma patients.

Telo Genomics reports positive interim results for blood test predicting relapse risk in multiple myeloma patients.

Telo Genomics announced positive interim results from a clinical study analyzing blood samples of multiple myeloma patients to predict relapse risk using 3D telomere analysis. The test showed strong predictive accuracy, potentially offering a less in...

Market News
Bullish
4 hours ago
Meta alerts parents if teens discuss self-harm with its AI chatbot, plans emergency contact feature.

Meta alerts parents if teens discuss self-harm with its AI chatbot, plans emergency contact feature.

Meta now notifies parents if their teen talks about suicide or self-harm with its AI chatbot and is developing a feature to contact emergency services if risk is detected. This move addresses concerns about AI chatbots handling crisis conversations, ...

Market News
Neutral
4 hours ago
Garmin launches G2000 PRIME, a premium flight deck for high-performance piston and electric aircraft.

Garmin launches G2000 PRIME, a premium flight deck for high-performance piston and electric aircraft.

Garmin introduced the G2000 PRIME, a new integrated flight deck designed for high-performance Class I/II piston and electric aircraft. It features large, edge-to-edge touchscreen displays with advanced multi-touch capabilities, faster processors, and...

Others
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App